303 related articles for article (PubMed ID: 29636462)
1. Mechanistic insights into allosteric regulation of the A
Ye L; Neale C; Sljoka A; Lyda B; Pichugin D; Tsuchimura N; Larda ST; Pomès R; García AE; Ernst OP; Sunahara RK; Prosser RS
Nat Commun; 2018 Apr; 9(1):1372. PubMed ID: 29636462
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Role of the G Protein in Stabilizing the Active State of the Adenosine A
Lee S; Nivedha AK; Tate CG; Vaidehi N
Structure; 2019 Apr; 27(4):703-712.e3. PubMed ID: 30713025
[TBL] [Abstract][Full Text] [Related]
3. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
[TBL] [Abstract][Full Text] [Related]
4. Ligand modulation of sidechain dynamics in a wild-type human GPCR.
Clark LD; Dikiy I; Chapman K; Rödström KE; Aramini J; LeVine MV; Khelashvili G; Rasmussen SG; Gardner KH; Rosenbaum DM
Elife; 2017 Oct; 6():. PubMed ID: 28984574
[TBL] [Abstract][Full Text] [Related]
5. Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding.
Keränen H; Gutiérrez-de-Terán H; Åqvist J
PLoS One; 2014; 9(10):e108492. PubMed ID: 25285959
[TBL] [Abstract][Full Text] [Related]
6. Structure of an agonist-bound human A2A adenosine receptor.
Xu F; Wu H; Katritch V; Han GW; Jacobson KA; Gao ZG; Cherezov V; Stevens RC
Science; 2011 Apr; 332(6027):322-7. PubMed ID: 21393508
[TBL] [Abstract][Full Text] [Related]
7. Delineating the conformational landscape of the adenosine A
Huang SK; Pandey A; Tran DP; Villanueva NL; Kitao A; Sunahara RK; Sljoka A; Prosser RS
Cell; 2021 Apr; 184(7):1884-1894.e14. PubMed ID: 33743210
[TBL] [Abstract][Full Text] [Related]
8. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
Sabbadin D; Ciancetta A; Moro S
J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
[TBL] [Abstract][Full Text] [Related]
9. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the adenosine A
Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the Allosteric Regulation of Sodium Cation on the Binding of Adenosine at the Human A
Bissaro M; Bolcato G; Deganutti G; Sturlese M; Moro S
Molecules; 2019 Jul; 24(15):. PubMed ID: 31362426
[TBL] [Abstract][Full Text] [Related]
12. Structure of a GRK5-Calmodulin Complex Reveals Molecular Mechanism of GRK Activation and Substrate Targeting.
Komolov KE; Sulon SM; Bhardwaj A; van Keulen SC; Duc NM; Laurinavichyute DK; Lou HJ; Turk BE; Chung KY; Dror RO; Benovic JL
Mol Cell; 2021 Jan; 81(2):323-339.e11. PubMed ID: 33321095
[TBL] [Abstract][Full Text] [Related]
13. Calcium modulates calmodulin/α-actinin 1 interaction with and agonist-dependent internalization of the adenosine A
Piirainen H; Taura J; Kursula P; Ciruela F; Jaakola VP
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):674-686. PubMed ID: 28130124
[TBL] [Abstract][Full Text] [Related]
14. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.
Segala E; Guo D; Cheng RK; Bortolato A; Deflorian F; Doré AS; Errey JC; Heitman LH; IJzerman AP; Marshall FH; Cooke RM
J Med Chem; 2016 Jul; 59(13):6470-9. PubMed ID: 27312113
[TBL] [Abstract][Full Text] [Related]
15. State-Targeting Stabilization of Adenosine A
Mitsumoto M; Sugaya K; Kazama K; Nakano R; Kosugi T; Murata T; Koga N
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884716
[TBL] [Abstract][Full Text] [Related]
16. Ligand-Dependent Sodium Ion Dynamics within the A
Hu X; Smith MD; Humphreys BM; Green AT; Parks JM; Baudry JY; Smith JC
J Phys Chem B; 2019 Sep; 123(38):7947-7954. PubMed ID: 31483659
[TBL] [Abstract][Full Text] [Related]
17. Mapping the allosteric sites of the A
Caliman AD; Miao Y; McCammon JA
Chem Biol Drug Des; 2018 Jan; 91(1):5-16. PubMed ID: 28639411
[TBL] [Abstract][Full Text] [Related]
18. Development of a high-throughput crystal structure-determination platform for JAK1 using a novel metal-chelator soaking system.
Caspers NL; Han S; Rajamohan F; Hoth LR; Geoghegan KF; Subashi TA; Vazquez ML; Kaila N; Cronin CN; Johnson E; Kurumbail RG
Acta Crystallogr F Struct Biol Commun; 2016 Nov; 72(Pt 11):840-845. PubMed ID: 27827355
[TBL] [Abstract][Full Text] [Related]
19. Allosteric Coupling of Drug Binding and Intracellular Signaling in the A
Eddy MT; Lee MY; Gao ZG; White KL; Didenko T; Horst R; Audet M; Stanczak P; McClary KM; Han GW; Jacobson KA; Stevens RC; Wüthrich K
Cell; 2018 Jan; 172(1-2):68-80.e12. PubMed ID: 29290469
[TBL] [Abstract][Full Text] [Related]
20. Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA.
Suno R; Kimura KT; Nakane T; Yamashita K; Wang J; Fujiwara T; Yamanaka Y; Im D; Horita S; Tsujimoto H; Tawaramoto MS; Hirokawa T; Nango E; Tono K; Kameshima T; Hatsui T; Joti Y; Yabashi M; Shimamoto K; Yamamoto M; Rosenbaum DM; Iwata S; Shimamura T; Kobayashi T
Structure; 2018 Jan; 26(1):7-19.e5. PubMed ID: 29225076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
